Replies to post #598981 on NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

Man I'm not advocating or dissing or anything. I don't give a rat's ass about NVCR. I find the 25% drop kinda funny, and that's about it. Not everything has to be agenda driven, calm down little buddy.

[Dan88]

Today's news re NVCR's lung cancer trial results is a huge wakeup call for both NVCR and NWBO investors, ans also for the general investment world:

NVCR has no future. NWBO will be the king starting today and in the future

[dstock07734]

Should SEC investigate the CEO of NVCR? Back in January, when the preliminary results were released, he dumped almost all his shares.

[exwannabe]

Your prior IC analysis is way off.

The trial as a whole had 31% treated with a CI in 1st line, In the trial SOC is physicians choice of chemo or CI. As is normal doctors rarely used CI if it had already failed. Thus only 2 % of patents who used 2nd line CI (the trial) had used it front line.

As far as "99%", nonsense. The label for front line is only for those with greater than 50% PD-1 expression or metastatic.

The news was bad (relatively), but I doubt you would know why,